establish
steroidassoci
osteonecrosi
saon
rabbit
model
found
recent
blockag
src
sirna
could
improv
reconstruct
repair
osteonecrosi
via
enhanc
osteogenesi
inhibit
bone
resorpt
current
studi
investig
block
src
abl
prevent
steroidassoci
osteoporosi
saop
saon
anim
model
rabbit
treat
puls
lipopolysaccharid
lp
corticosteroid
methylprednisolon
mp
week
induct
src
sirna
control
sirna
salin
intramedullari
inject
proxim
femur
respect
two
fluoresc
dye
xylenol
orang
calcein
green
inject
sacrif
anim
vivo
label
newli
form
bone
week
induct
proxim
femora
rabbit
dissect
microct
histolog
analysi
result
show
signific
bone
loss
metaphysi
femor
head
control
rabbit
saon
induct
src
sirna
treatment
abl
prevent
steroidassoci
bone
loss
trabecular
bone
increas
cortic
bone
thick
femor
neck
histomorphometri
show
src
sirna
increas
osteoblast
bone
format
decreas
erod
bone
surfac
suggest
decreas
osteoclast
bone
resorpt
first
studi
report
bone
loss
saon
induct
rabbit
model
could
prevent
knock
src
sirna
corticosteroid
wide
indic
mani
diseas
attribut
antiinflamm
effect
howev
longterm
use
could
lead
advers
effect
steroidassoci
osteoporosi
saop
andor
steroidassoci
osteonecrosi
saon
saop
patient
decreas
bone
miner
densiti
bmd
report
higher
risk
bone
fractur
advanc
saon
patient
often
suffer
joint
collaps
physiolog
skeleton
undergo
remodel
osteoclast
resorb
old
bone
osteoblast
form
new
bone
toward
mainten
bone
homeostasi
corticosteroid
impair
osteoblast
osteogenesi
increas
apoptosi
osteoblast
osteocyt
regard
common
pathway
underli
mechan
corticosteroidsassoci
bone
deterior
saop
saon
protooncogen
tyrosineprotein
kinas
src
also
known
csrc
particip
regul
wide
rang
cell
function
includ
adhes
motil
prolifer
surviv
skelet
system
src
inhibit
osteoblast
differenti
report
decreas
src
express
enhanc
osteoblast
differenti
bone
format
src
also
involv
regul
osteoclast
bone
resorpt
essenti
function
osteoclast
via
regul
osteoclast
skeleton
transgen
express
src
also
rescu
osteoclast
function
src
knockout
mice
modifi
saon
rabbit
model
found
destruct
repair
subchondr
region
femor
head
ie
domin
old
bone
resorpt
without
adequ
new
bone
format
maintain
normal
bone
homeostasi
knockdown
src
express
src
specif
sirna
could
enhanc
osteoblast
differenti
promot
osteogenesi
inhibit
function
osteoclast
word
src
sirna
may
also
potenti
treatment
saop
studi
investig
corticosteroidassoci
bone
loss
metaphysi
femor
head
use
establish
saon
rabbit
model
potenti
effect
src
sirna
prevent
saop
fortyeight
male
newzealand
white
rabbit
kg
hous
experiment
anim
center
princ
wale
hospit
hong
kong
receiv
standard
laboratori
diet
water
ad
libitum
specifi
experiment
protocol
approv
anim
experi
ethic
committe
chines
univers
hong
kong
base
establish
protocol
induc
destruct
repair
saon
thirtysix
rabbit
use
intraven
inject
lipopolysaccharid
lp
bodi
weight
escherichia
coli
sigmaaldrich
st
loui
mo
usa
day
day
intramuscularli
inject
corticosteroid
methylprednisolon
mp
mgkg
bodi
weight
pharmacia
upjohn
peapack
nj
usa
day
day
twelv
rabbit
without
treatment
use
normal
control
week
induct
puls
lp
mp
rabbit
gener
anesthesia
intramuscular
inject
xylazin
mgkg
bodi
weight
ketamin
mgkg
bodi
weight
hair
shave
hip
region
prep
iodin
tinctur
ethanol
later
digit
xray
hip
taken
monitor
inject
site
order
prove
intervent
concept
adopt
local
deliveri
approach
g
needl
select
local
sirna
administr
control
well
insert
greater
trochant
proxim
femur
marrow
caviti
femur
neck
lpsmp
treat
rabbit
randomli
divid
three
group
n
ssisrc
group
nmol
src
sirna
synthes
ribobio
guangzhou
ribobio
co
ltd
sens
uca
cca
uca
agu
cag
antisens
gac
uug
aug
gug
aac
c
intramedullari
inject
proxim
femur
vivojetpei
polyplu
transfect
strasbourg
franc
transfect
reagent
accord
manufactur
protocol
snc
group
nmol
neg
control
sirna
synthes
ribobio
sens
ucc
gaa
cgu
guc
acg
u
antisens
uga
cac
guu
cgg
aga
inject
method
describ
svc
group
vehicl
control
ml
salin
inject
euthanasia
execut
day
week
administr
group
femora
collect
evalu
ml
bone
marrow
extract
inject
site
inject
mrna
isol
mini
kit
qiagen
usa
cdna
revers
transcript
revers
transcript
kit
qiagen
usa
realtim
pcr
perform
abi
prism
sequenc
detect
system
appli
biosystem
foster
citi
ca
usa
use
tf
pack
power
sybr
green
pcr
ma
appli
biosystem
foster
citi
ca
usa
primer
rabbit
srcforward
srcrevers
gapdhforward
gapdhrevers
day
day
euthanasia
two
fluoresc
dye
xylenol
orang
mgkg
bodi
weight
calcein
green
mgkg
bodi
weight
sigmaaldrich
gmbh
inject
sequenti
subcutan
rabbit
n
euthanasia
proxim
femora
embed
methyl
methacryl
mma
without
decalcif
fix
buffer
formalin
one
week
proxim
femora
scan
use
microct
scanco
medic
switzerland
spatial
resolut
order
separ
miner
tissu
background
signal
lowpass
gaussian
filter
sigma
support
use
miner
tissu
defin
threshold
hu
section
scan
femor
head
reconstruct
structur
evalu
metaphys
trabecular
architectur
femor
head
predetermin
bone
cylind
use
roi
mm
diamet
mm
height
quantifi
volumetr
bone
miner
densiti
bmd
bone
tissu
volum
fraction
bvtv
connect
densiti
conn
trabecular
number
tb
n
trabecular
thick
tbth
trabecular
separ
tb
sp
evalu
cortic
bone
femor
neck
use
roi
mm
thick
realign
microct
imag
use
builtin
softwar
ipl
imag
process
languag
fig
dual
threshold
techniqu
use
automat
segment
cortic
ring
femor
neck
first
threshold
outer
contour
second
threshold
inner
contour
set
hu
use
microct
builtin
evalu
method
long
bone
midshaft
evalu
cortic
bone
thick
ctth
periost
diamet
psdm
endost
diamet
esdm
polar
moment
inertia
pmoi
determin
pmoi
ixx
iyi
ixx
moi
around
xaxi
iyi
moi
around
yaxi
decalcifi
section
proxim
femora
treat
edta
ph
week
weekli
refresh
decalcifi
solut
n
decalcif
process
assess
digit
xray
complet
decalcif
confirm
without
show
radiograph
opac
proxim
femora
embed
paraffin
cut
section
along
coron
plane
section
stain
h
e
histomorphometri
tartrateresist
acid
phosphatas
trap
sigma
diagnost
st
loui
missouri
usa
identif
osteoclast
mma
embed
sampl
cut
along
coron
plane
use
saw
microtom
leica
leica
instrument
nussloch
germani
polish
polish
phoenix
buehler
ltd
usa
observ
fluoresc
label
cut
section
use
microton
leica
dynam
histomorphometri
goldner
trichrom
stain
histolog
imag
digit
microscop
imag
system
leica
leica
microsystem
wetzlar
germani
histomorphometr
analysi
carri
metaphysi
femor
head
mm
width
area
growth
plate
use
osteomeasur
histomorphometri
system
osteometr
atlanta
ga
usa
analyz
accord
standard
histomorphometri
protocol
data
express
mean
sd
oneway
anova
follow
bonferroni
posttest
compar
group
differ
statist
analysi
perform
use
spss
softwar
chicago
il
usa
p
b
consid
signific
quantit
realtim
pcr
show
src
mrna
level
bone
marrow
ssisrc
group
consist
lower
week
inject
compar
snc
group
throughout
experiment
period
p
b
src
mrna
level
bone
marrow
snc
differ
compar
svc
group
fig
use
microct
analyz
metaphys
trabecular
architectur
femor
head
reveal
signific
lower
bone
tissu
volum
fraction
bvtv
trabecular
thick
tbth
connect
densiti
conn
svcsnc
group
compar
normal
control
group
p
b
contrari
metaphys
trabecular
bone
show
signific
higher
bone
miner
densiti
bmd
p
b
bvtv
p
b
tbth
p
b
conn
p
b
ssisrc
group
compar
svcsnc
group
significantli
differ
microct
paramet
svc
snc
group
fig
microct
imag
femor
neck
show
cortic
thin
occur
svc
group
snc
group
region
adjac
greater
trochant
lesser
trochant
compar
correspond
region
normal
control
group
thin
region
even
disconnect
region
adjac
greater
trochant
fig
averag
thick
whole
ring
cortic
bone
femor
neck
ctth
show
statist
significantli
differ
svcsnc
group
normal
control
group
ctth
polar
moment
inertia
pmoi
significantli
larger
ssisrc
group
compar
svcsnc
group
p
b
periost
diamet
psdm
endost
diamet
esdm
significantli
differ
among
group
fig
histomorphometr
analysi
perform
metaphysi
femor
head
fig
decalcifi
section
found
osteoblast
surfac
obsb
svcsnc
group
differ
normal
control
group
ratio
erod
surfac
total
bone
surfac
esb
osteoclast
number
per
bone
surfac
nocb
significantli
larger
induct
fig
signific
differ
nocb
ssisrc
group
svcsnc
group
noce
valu
significantli
larger
ssisrc
group
compar
svc
group
p
b
fig
undecalcifi
section
result
show
svcsnc
group
miner
apposit
rate
mar
osteoid
thick
owi
lower
compar
normal
control
group
p
b
miner
surfac
msb
show
signific
differ
bone
format
rate
bfrb
significantli
lower
svcsnc
group
compar
normal
control
group
p
b
src
sirna
treatment
affect
mar
owi
compar
svcsnc
group
msb
bfrb
significantli
higher
ssisrc
group
compar
svcsnc
group
p
b
fig
descript
histolog
analysi
femor
neck
summar
supplement
fig
sequenti
fluoresc
label
show
newli
form
bone
endost
surfac
includ
endocort
intracort
trabecular
surfac
observ
littl
scatter
newli
form
bone
periost
surfac
femor
neck
group
supplement
fig
goldner
trichrom
stain
show
osteoid
endocort
intracort
surfac
normal
control
group
ssisrc
group
osteoclast
bone
resorpt
svc
snc
group
ssisrc
group
osteoclast
bone
resorpt
hardli
observ
supplement
fig
studi
investig
bone
loss
induc
puls
lp
mp
use
establish
saon
rabbit
model
test
therapeut
potenti
src
sirna
bone
anabol
antiresorpt
agent
prevent
corticosteroid
associ
osteoporosi
saop
microct
analysi
show
signific
deterior
trabecular
bone
metaphysi
femor
head
lpsmp
induct
compar
normal
control
group
character
signific
inferior
valu
bvtv
tb
th
conn
metaphys
trabecular
bone
femor
head
svcsnc
group
histomorphometri
result
show
bone
loss
explain
increas
osteoclast
bone
resorpt
increas
osteoclast
number
nocb
erod
surfac
decreas
osteoblast
bone
format
accompani
decreas
miner
apposit
rate
mar
bone
format
rate
bfrb
wellknown
corticosteroid
induc
bone
resorpt
longterm
administr
corticosteroid
would
lead
inhibit
osteoclast
bone
resorpt
reduc
bone
turnov
induct
protocol
puls
high
dose
corticosteroid
administr
simul
clinic
situat
one
develop
treatment
sever
acut
respiratori
syndrom
sar
patient
hong
kong
result
lower
bmd
hip
saon
patient
around
osteonecrot
lesion
osteoclast
also
stimul
resorb
necrot
trabecular
bone
repair
process
studi
investig
corticosteroidassoci
bone
loss
use
establish
saon
rabbit
model
found
coexist
osteonecrosi
osteoporosi
anim
model
howev
roi
osteonecrosi
osteoporosi
differ
made
evalu
possibl
comparison
subchondr
region
yellow
bone
marrow
low
bone
remodel
rate
normal
rabbit
elev
bone
resorpt
bone
format
model
anim
roi
studi
repair
osteonecrosi
metaphysi
red
bone
marrow
normal
bone
remodel
roi
assess
bone
loss
associ
corticosteroid
treatment
current
studi
although
apoptosi
osteoblast
osteocyt
induc
puls
lp
mp
inevit
occur
regard
common
pathway
underli
mechan
corticosteroidsassoci
bone
deterior
saop
saon
form
structur
basi
novel
find
src
sirna
prevent
saop
current
studi
puls
lp
mp
treatment
downregul
metabol
activ
osteoblast
shown
decreas
mar
svcsnc
group
similar
find
also
report
previou
studi
saop
howev
osteoblast
surfac
obsb
miner
surfac
msb
significantli
differ
svc
normal
control
inconsist
might
explain
osteonecrot
repair
progress
anim
model
pure
saop
decreas
osteoblast
differenti
prolifer
microct
imag
femor
neck
show
cortic
thin
puls
lpsmp
treatment
compar
normal
control
group
particular
region
adjac
greater
trochant
lesser
trochant
cortic
thick
origin
thinner
compar
trabecular
bone
thick
make
region
sensit
lpsmp
overal
chang
cortic
thick
found
statist
signific
might
explain
rather
short
effect
cortic
bone
use
current
puls
mp
lp
treatment
protocol
regard
saon
saop
apart
mp
lp
also
administ
rabbit
model
simul
clinic
indic
treatment
system
inflamm
report
lp
could
inhibit
osteoblast
differenti
induc
osteoblast
apoptosi
could
promot
osteoclast
differenti
surviv
suggest
lp
potenti
contribut
pathogenesi
bone
loss
rabbit
model
well
although
could
delin
effect
corticosteroid
also
report
lp
could
induc
src
express
activ
macrophag
ie
lineag
osteoclast
potenti
contribut
activ
bone
resorpt
loss
trabecular
bone
metaphysi
femor
head
puls
lp
mp
treatment
revers
src
sirna
administr
present
studi
significantli
better
microct
indic
includ
bmd
bvtv
tb
th
conn
histomorphometri
result
confirm
src
sirna
administr
obsb
msb
bfrb
significantli
higher
suggest
sisrc
could
enhanc
osteoblast
differenti
rabbit
model
howev
mar
owi
ssisrc
group
differ
svcsnc
group
impli
sisrc
affect
function
matur
osteoblast
find
also
support
earli
work
use
src
knockdown
mice
vivo
report
inhibit
src
calvari
osteoblast
mice
vitro
could
lead
enhanc
alp
activ
nodul
miner
enhanc
alp
activ
relat
enhanc
alp
posit
cell
number
known
src
famili
inhibit
osteoblast
signal
pathway
tyrosin
phosphoryl
yesassoci
protein
yap
suppress
transcript
activ
major
transcript
factor
control
osteoblastogenesi
report
src
stimul
induc
insulinlik
growth
factor
src
activ
factor
immatur
osteoblast
maintain
osteoblast
less
matur
statu
suggest
could
differ
pathway
src
regul
immatur
matur
osteoblast
might
reason
inhibit
src
stimul
osteoblast
differenti
matur
without
stimul
osteoblast
function
present
studi
found
nocb
affect
sisrc
suggest
src
direct
effect
osteoclast
differenti
howev
sisrc
significantli
decreas
esb
increas
n
oce
suggest
sisrc
could
inhibit
osteoclast
bone
resorpt
inhibit
bone
resorpt
function
osteoclast
higher
n
oce
mean
chang
number
osteoclast
noc
erod
surfac
es
lower
interpret
lower
averag
activ
osteoclast
function
src
osteoclast
role
regul
cytoskelet
organ
organ
cytoskeleton
osteoclast
show
effect
synthesi
secret
collagenolyt
cystein
proteas
cathepsin
k
inhibit
src
report
suppress
secret
cathepsin
bone
resorpt
osteoclast
impli
src
involv
activ
bone
resorpt
well
report
lifespan
osteoclast
week
vivo
lifespan
longer
glucocorticoid
excess
explain
biweekli
treatment
sirna
sustain
therapeut
effect
osteoclast
bone
resorpt
current
studi
also
found
sisrc
could
enhanc
cortic
bone
thick
polar
moment
inertia
pmoi
indic
torsion
rigid
microct
reveal
femor
neck
cortic
thick
ssisrc
group
significantli
increas
compar
svcsnc
group
clinic
bmd
measur
femor
neck
standard
measur
diagnos
osteoporosi
found
pmoi
also
correl
bone
strength
apart
bmd
bone
fractur
occur
predominantli
cortic
site
qualiti
cortic
bone
femor
neck
play
import
role
predict
fractur
risk
fluoresc
label
show
new
bone
format
endocort
surfac
intracort
surfac
supplement
fig
endost
surfac
includ
endocort
intracort
trabecular
surfac
cell
commun
trabecular
cortic
bone
bone
model
remodel
src
sirna
could
enhanc
osteogenesi
trabecular
surfac
also
endost
surfac
intracort
surfac
enhanc
bone
qualiti
decreas
bone
fractur
risk
saop
limit
microct
resolut
use
current
studi
determin
cortic
poros
femor
neck
howev
report
drug
antiresorpt
effect
could
reduc
cortic
poros
anabol
agent
could
increas
cortic
poros
increas
cortic
thick
decreas
risk
fractur
larger
poros
newli
form
bone
near
marrow
caviti
src
sirna
test
present
studi
could
inhibit
src
activ
dual
function
includ
antiresorpt
anabol
effect
result
increas
cortic
bone
qualiti
periost
bone
surfac
also
abund
number
osteoblast
preosteoclast
mononuclear
trap
respons
cortic
bone
remodel
suggest
knockdown
src
cell
would
also
antiresorpt
anabol
effect
increas
periost
diamet
howev
due
limit
microct
resolut
also
variat
anim
bone
size
current
crosssect
studi
group
comparison
shown
statist
differ
cortic
periost
psdm
endost
diamet
esdm
longitudin
studi
monitor
chang
bone
size
anim
nanoscal
analysi
desir
futur
studi
studi
biolog
therapeut
effect
design
src
sirna
bone
remodel
cortic
bone
current
studi
relat
local
inject
src
inhibit
effect
expect
show
mainli
bone
marrow
endost
surfac
futur
studi
would
focu
r
system
administr
src
sirna
knockdown
effici
cortic
bone
especi
periost
region
first
studi
explor
therapeut
effect
src
sirna
saop
local
inject
target
organ
tissu
expect
much
effici
eg
lower
dose
could
alreadi
achiev
therapeut
effect
current
proofofconcept
studi
high
risk
skelet
site
osteoporosi
osteoporot
fractur
compar
system
administr
rather
lower
treatment
effici
vivo
distribut
src
sirna
demonstr
h
inject
inject
sirna
retain
inject
site
small
part
sirna
transfect
local
inject
site
catabol
liver
excret
gallbladd
supplement
fig
howev
concern
clinic
applic
futur
studi
may
focu
r
system
bonetarget
deliveri
system
src
sirna
treat
system
saop
conclus
found
corticosteroidassoci
osteoporosi
establish
rabbit
saon
model
knockdown
src
src
sirna
could
increas
bone
format
decreas
bone
resorpt
therefor
could
becom
potenti
novel
therapeut
strategi
prevent
corticosteroidassoci
secondari
osteoporosi
supplementari
data
articl
found
onlin
http
dx
author
declar
conflict
interest
present
studi
